Skip to content
10-K

Annual Report

Targeted Medical Pharma, Inc.

0001493152-15-001421

← back to feed
Filed
Apr 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Apr 13, 2015 26.77M sh
Capex FY 2014 · Dec 31, 2013 $37.99K
Operating Cash Flow FY 2014 · Dec 31, 2013 −$2.05M
Current Liabilities FY 2014 · Dec 31, 2013 $11.26M
Total Liabilities FY 2014 · Dec 31, 2013 $12.02M
Current Assets FY 2014 · Dec 31, 2013 $2.63M
Total Assets FY 2014 · Dec 31, 2013 $5M
Sga Expense FY 2014 · Dec 31, 2013 $10.18M
Rd Expense FY 2014 · Dec 31, 2013 $228.61K
Net Income FY 2014 · Dec 31, 2013 −$9.34M
Operating Income FY 2014 · Dec 31, 2013 −$3.84M
Gross Profit FY 2014 · Dec 31, 2013 $6.57M
Cost Of Revenue FY 2014 · Dec 31, 2013 $2.99M
Revenue FY 2014 · Dec 31, 2013 $9.56M
Cash And Equivalents FY 2014 · Dec 31, 2012 $326.6K
Stockholders Equity FY 2014 · Dec 31, 2012 −$2M